Feinstein Institutes Decodes Diving Reflex Mechanism, Unlocking Potential Brain Injury Treatments
Event summary
- Scientists at Feinstein Institutes decoded the molecular mechanism behind the diving reflex, a protective response that conserves oxygen in the brain.
- The research reveals the trigeminal nerve releases CGRP to activate Nrf2, boosting antioxidant defenses without cellular stress.
- Experiments showed the reflex-driven therapy rescued damaged brain cells and improved cognitive function in vascular dementia models.
- The diving reflex operates in two stages: a rapid 30-minute response and a long-term adaptive response for sustained protection.
The big picture
The discovery positions the diving reflex as a novel strategy for treating brain injuries and neurodegenerative diseases, aligning with the growing trend in bioelectronic medicine. The Feinstein Institutes' research could redefine how protective mechanisms are harnessed on-demand, potentially disrupting traditional drug-based approaches.
What we're watching
- Therapeutic Development
- How the molecular blueprint of the diving reflex will accelerate CGRP-targeting pharmaceuticals and bioelectronic devices.
- Clinical Translation
- The pace at which this research transitions from lab models to human trials for conditions like traumatic brain injury and stroke.
- Market Potential
- Whether the diving reflex mechanism can be leveraged for a broader range of neurodegenerative diseases beyond vascular dementia.
Related topics